![Larry Glass](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Larry Glass
Technik-/Wissenschafts-/F&E-Leiter bei NEUREN PHARMACEUTICALS LIMITED
Profil
Lawrence Glass is currently a Director at Hamilton Pharmaceuticals, Inc., Perseis Therapeutics Ltd., Neuren Pharmaceuticals, Inc., and Neuren Pharmaceuticals (Australia) Pty Ltd.
He is also the Chief Science Officer at Neuren Pharmaceuticals Ltd.
Mr. Glass previously served as the Chief Executive Officer at Contract Research Organization.
Aktive Positionen von Larry Glass
Unternehmen | Position | Beginn |
---|---|---|
NEUREN PHARMACEUTICALS LIMITED | Technik-/Wissenschafts-/F&E-Leiter | - |
Hamilton Pharmaceuticals, Inc.
![]() Hamilton Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Hamilton Pharmaceuticals, Inc. develops and supplies pharmaceuticals. It also develops and commercializes novel medical treatments for central nervous system disease. The company was founded in April 2004 and is headquartered in Washington, DC. | Direktor/Vorstandsmitglied | 09.07.2014 |
Neuren Pharmaceuticals, Inc. | Direktor/Vorstandsmitglied | - |
Neuren Pharmaceuticals (Australia) Pty Ltd. | Direktor/Vorstandsmitglied | - |
Perseis Therapeutics Ltd. | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Larry Glass
Unternehmen | Position | Ende |
---|---|---|
Contract Research Organization | Vorstandsvorsitzender | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
NEUREN PHARMACEUTICALS LIMITED | Health Technology |
Private Unternehmen | 5 |
---|---|
Hamilton Pharmaceuticals, Inc.
![]() Hamilton Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Hamilton Pharmaceuticals, Inc. develops and supplies pharmaceuticals. It also develops and commercializes novel medical treatments for central nervous system disease. The company was founded in April 2004 and is headquartered in Washington, DC. | Commercial Services |
Neuren Pharmaceuticals, Inc. | |
Neuren Pharmaceuticals (Australia) Pty Ltd. | |
Perseis Therapeutics Ltd. | |
Contract Research Organization |